Advances in hormonal contraception.
This article presents a review of advances made in hormonal contraception over the past 15 years. It looks at the different routes of administration that have been developed, at newer formulations of conventional methods, and at novel contraceptive agents that are in the process of approval. The article provides a short description of each of these contraceptive methods, information about compliance, side effects, and efficacy, and an update on that particular method.
Gupta
Nupur
N
Tufts University School of Medicine, Boston, MA 02111, USA. nupur.gupta@tufts.edu
D000279:Administration, Cutaneous; D000282:Administration, Intravaginal; D003271:Contraceptive Agents, Female / Q000008:administration & dosage / Q000009:adverse effects; D003281:Contraceptives, Postcoital; D003692:Delayed-Action Preparations; D004338:Drug Combinations; D004997:Ethinyl Estradiol / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007279:Injections, Subcutaneous; D007434:Intrauterine Devices; D016912:Levonorgestrel / Q000009:adverse effects / Q000627:therapeutic use; D017258:Medroxyprogesterone Acetate / Q000009:adverse effects / Q000627:therapeutic use; D009644:Norgestrel / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use
D003271:Contraceptive Agents, Female; D003281:Contraceptives, Postcoital; D003692:Delayed-Action Preparations; D004338:Drug Combinations; C511292:Ortho Evra; D009644:Norgestrel; D004997:Ethinyl Estradiol; D016912:Levonorgestrel; D017258:Medroxyprogesterone Acetate